-
Awan A R, Zahoor M Y, Javed M M, Babar M E, Saleem Z, 2012: Expression of pres2/S antigen of hepatitis B virus isolated from Pakistan in yeast cells[J]. Pak. J. Bot., 44, 355-359.
-
Cabral G A, Marciano-Cabral F, Funk G A, Sanchez Y, Hollinger F B, Melnick J L, Dreesman G R, 1978: Cellular and humoral immunity in guinea pigs to two major polypeptides derived from hepatitis B surface antigen[J]. J Gen Virol, 38, 339-350. doi: 10.1099/0022-1317-38-2-339
-
Chen H, Chuai X, Deng Y, Wen B, Wang W, Xiong S, Ruan L, Tan W, 2012: Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine[J]. PLoS One, 7, e43730-. doi: 10.1371/journal.pone.0043730
-
Chi S W, Kim D H, Kim J S, Lee M K, Han K H, 2006: Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen[J]. Antiviral Res, 72, 207-215. doi: 10.1016/j.antiviral.2006.06.009
-
Faber K N, Haima P, Harder W, Veenhuis M, Ab G, 1994: Highly-efficient electrotransformation of the yeast Hansenula polymorpha[J]. Curr Genet, 25, 305-310. doi: 10.1007/BF00351482
-
G.Birkenmeyer L, 2003: Hepatitis B virus: life cycle and morphogenesis. In: Ias K M (ed.)[J]. Perspectives in Medical Virology, Elsevier, 10, 109-125. doi: 10.1016/S0168-7069(03)10004-3
-
Gellissen G, Janowicz Z A, Weydemann U, Melber K, Strasser A W, Hollenberg C P, 1992: High-level expression of foreign genes in Hansenula polymorpha[J]. Biotechnol Adv, 10, 179-189. doi: 10.1016/0734-9750(92)90002-Q
-
Hadiji-Abbes N, Borchani-Chabchoub I, Triki H, Ellouz R, Gargouri A, Mokdad-Gargouri R, 2009: Expression of HBsAg and preS2-S protein in different yeast based system: a comparative analysis[J]. Protein Expr Purif, 66, 131-137. doi: 10.1016/j.pep.2009.03.006
-
Hardy E, Martinez E, Diago D, Diaz R, Gonzalez D, Herrera L, 2000: Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris[J]. J Biotechnol, 77, 157-167. doi: 10.1016/S0168-1656(99)00201-1
-
Huang Y, Bi J, Zhang Y, Zhou W, Li Y, Zhao L, Su Z, 2007: A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha[J]. Protein Expr Purif, 56, 301-310. doi: 10.1016/j.pep.2007.08.009
-
Janssen H L, van Zonneveld M, Senturk H, Zeuzem S, Akarca U S, Cakaloglu Y, Simon C, So T M, Gerken G, de Man R A, Niesters H G, Zondervan P, Hansen B, Schalm S W, 2005: Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial[J]. Lancet, 365, 123-129. doi: 10.1016/S0140-6736(05)17701-0
-
Kuroda S, Fujisawa Y, Iino S, Akahane Y, Suzuki H, 1991: Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)[J]. Vaccine, 9, 163-169. doi: 10.1016/0264-410X(91)90148-Y
-
Langley K E, Egan K M, Barendt J M, Parker C G, Bitter G A, 1988: Characterization of purified hepatitis B surface antigen containing pre-S (2) epitopes expressed in Saccharomyces cerevisiae[J]. Gene, 67, 229-245. doi: 10.1016/0378-1119(88)90400-3
-
Lian M, Zhou X, Chen B, Li C, Gu X, Luo M, Zheng X, 2008: Identification of the critical regions in hepatitis B virus preS required for its stability[J]. J Pept Sci, 14, 307-312. doi: 10.1002/psc.929
-
Liaw Y F, Leung N W, Chang T T, Guan R, Tai D I, Ng K Y, Chien R N, Dent J, Roman L, Edmundson S, Lai C L, 2000: Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.[J]. Gastroenterology, 119, 172-180. doi: 10.1053/gast.2000.8559
-
Milich D R, Thornton G B, Neurath A R, Kent S B, Michel M L, Tiollais P, Chisari F V, 1985: Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen[J]. Science, 228, 1195-1199. doi: 10.1126/science.2408336
-
Niederau C, Heintges T, Lange S, Goldmann G, Niederau C M, Mohr L, Haussinger D, 1996: Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B[J]. N Engl J Med, 334, 1422-1427. doi: 10.1056/NEJM199605303342202
-
Sjogren M H, 2005: Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination[J]. Am J Med, 118, 34S-39S.
-
Torbenson M, Thomas D L, 2002: Occult hepatitis B[J]. Lancet Infect Dis, 2, 479-486. doi: 10.1016/S1473-3099(02)00345-6
-
Jiang Z G, Wang Y, Shao X A, Yue Y, Hong X W, Xu L, Xiong S D, 2007: Antibodized gene vaccine harboring to HBV PreS2/S gene can enhance HBV specific CTL response induced by gene immunization[J]. Chinese J Immunol, , 963-967.